A rare case of arthritis and fever;Un cas rare d'arthrite febrile

Revue Medicale de Liege

Volumn 68, Issue 7-8, 2013, Pages 423-427

  Rinkin, C ^a   Van Durme, C ^a   Fautrel, B ^b   Malaise, M ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Adult onset Still's disease; Anakinra; AOSD; Inflammasome

Indexed keywords

CORTICOSTEROID; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; ADULT ONSET STILL DISEASE; ARTHRALGIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; HUMAN; HYPERFERRITINEMIA; INFLAMMATION; MALE; RASH; RECURRENT FEVER;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; ARTHRALGIA; FEVER; GLUCOCORTICOIDS; HUMANS; MALE; STILL'S DISEASE, ADULT-ONSET;

EID: 84884230379     PISSN: 0370629X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kontzias A, Efthimiou P. - Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances. Drugs, 2008, 68, 319-337.
2. Church LD, Cook GP, McDermott MF. - Primer : inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol, 2008, 4, 34-42.
3. Bywaters EG. - Still's disease in the adult. Ann Rheum Dis, 1971, 30, 121-133.
4. Magadur-Joly G, Billaud E, Barrier JH, et al. - Epidemiology of adult Still's disease : estimate of the incidence by a retrospective study in west France. Ann Rheum Dis, 1995, 54, 587-590.
5. Yamaguchi M, Ohta A, Tsunematsu T, et al. - Preliminary criteria for classification of adult Still's disease. J Rheumatol, 1992, 19, 424-430.
6. Fautrel B, Zing E, Golmard J-L, et al. - Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore), 2002, 81, 194-200.
7. Fautrel B, Le Moël G, Saint-Marcoux B, et al. - Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol, 2001, 28, 322-329.
8. Fautrel B. - Adult-onset Still disease. Best Pract Res Clin Rheumatol, 2008, 22, 773-792.
9. Mavragani CP, Spyridakis EG, Koutsilieris M. - Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies. Intern J Inflammation, 2012, 2012, 879020.
10. Giampietro C, Fautrel B. - Anti-Interleukin-1 Agents in Adult Onset Still's Disease. Int J Inflam, 2012, 2012, 317820.
11. Fujii T, Akizuki M, Kameda H, et al. - Methotrexate treatment in patients with adult onset Still's disease-retrospective study of 13 Japanese cases. Ann Rheum Dis, 1997, 56, 144-148.
12. Shojania K, Chalmers A, Rangno K. - Cyclosporin A in the treatment of adult Still's disease. J Rheumatol, 1995, 22, 1391-1392.
13. Vignes S, Wechsler B, Amoura Z, et al. - Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol, 1998, 16, 295-298.
14. Husni ME, Maier AL, Mease PJ, et al. - Etanercept in the treatment of adult patients with Still's disease. Arthritis Rheum, 2002, 46, 1171-1176.
15. Kraetsch HG, Antoni C, Kalden JR, et al. - Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences. Ann Rheum Dis, 2001, 60 Suppl 3, iii55-57.
16. Thonhofer R, Hiller M, Just H, et al. - Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature. Rheumatol Int, 2011, 31, 1653-1656.
17. Laskari K, Tzioufas AG, Moutsopoulos HM. - Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study. Arthritis Res Ther, 2011, 13, R91.
18. Kötter I, Wacker A, Koch S, et al. - Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthritis Rheum, 2007, 37, 189-197.
19. Petryna O, Cush JJ, Efthimiou P. - IL-1 Trap rilonacept in refractory adult onset Still's disease. Annals of the rheumatic diseases Published Online First : 7 June 2012. doi:10.1136/annrheumdis-2012-201409
20. Kontzias A, Efthimiou P. - The Use of Canakinumab, a Novel IL-1β Long-Acting Inhibitor, in Refractory Adult-Onset Still's Disease. Seminars in arthritis and rheumatism Published Online First : 16 April 2012. doi:10.1016/j.semarthrit.2012.03.004